HHealth Read More Why are men more likely to develop multiple myeloma than women?January 13, 2026 A study has unearthed potential reasons for sex differences that are observed in the clinical presentation of patients…
HHealth Read More Multiple myeloma rates increasing twice as high in men than in womenJanuary 12, 2026 Rates of multiple myeloma (MM), the second most common blood cancer in the United States, are increasing and…
HHealth Read More Largest Immune Cell Atlas of Multiple Myeloma Predicts Recurrence RiskJanuary 10, 2026 Credit: Md Saiful Islam Khan / iStock / Getty Images Plus Scientists across six leading U.S. institutions have…
HHealth Read More Antibody Therapy Eradicates Traces of Multiple Myeloma in Preliminary TrialDecember 7, 2025 By: Wynne Parry | December 06, 2025 | 7 min. read | Share Summary Sylvester Comprehensive Cancer Center researchers…
HHealth Read More A plain language summary of the CEPHEUS study: D-VRd for newly diagnosed multiple myeloma patients who are not expected to receive a stem cell transplantNovember 10, 2025 The CEPHEUS study evaluated the effectiveness of adding daratumumab to the standard VRd regimen (bortezomib, lenalidomide, and dexamethasone)…
GGenetics Read More Tip Sheet: What cancer patients need to know about tumor markers, a new cancer genetics atlas — and educational programs for students and teachersSeptember 3, 2025 SEATTLE — Sept. 3, 2025 — Below are summaries of recent Fred Hutch Cancer Center research findings, patient…
GGenetics Read More Tip Sheet: What cancer patients need to know about tumor markers, a new cancer genetics atlas — and educational programs for students and teachersSeptember 3, 2025 SEATTLE — Sept. 3, 2025 — Below are summaries of recent Fred Hutch Cancer Center research findings, patient…
GGenetics Read More Genomic clues uncover early origins of multiple myelomaSeptember 1, 2025 A new study maps out the timeline of DNA damage for multiple myeloma, the second most common blood…